Table 2.
Structures of tested derivatives and determined concentrations of LC50.
![]() | |||
|---|---|---|---|
| Compound | R | LC50 (mg/mL) | LC50 (μM) |
| I-1 | ![]() |
0.61 | 1.73 |
| I-2 | ![]() |
5.04 | 14.16 |
| I-3 | ![]() |
very low activity, not specified | very low activity, not specified |
| I-4 | ![]() |
4.40 | 11.99 |
![]() | |||
| Compound | R | LC50 (mg/mL) | LC50 (μM) |
| II-1 | ![]() |
0.30 | 0.90 |
| II-2 | ![]() |
3.74 | 11.06 |
| II-3 | ![]() |
4.20 | 11.20 |
| II-4 | ![]() |
0.75 | 2.15 |
| Control | |||
| Albendazole | 19.78 | 74.55 | |









